Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap

Xiaoli Zhang,1,* Yuqing Chen,1,* Liyu Fan,1,* Jiaqi Ye,1 Junsheng Fan,2 Xinjie Xu,1 Danming You,3 Sihan Liu,3 Xin Chen,1 Peng Luo1 1Department of Respiratory Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, China; 2Department of Respiratory Medicine, Shanghai Tenth People&rsqu...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Zhang X, Chen Y, Fan L, Ye J, Fan J, Xu X, You D, Liu S, Chen X, Luo P
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Dove Medical Press 2018-08-01
Saila:	Drug Design, Development and Therapy
Gaiak:	asthma-chronic obstructive pulmonary disease overlap roflumilast phosphodiesterase-4 inhibitors mechanism.
Sarrera elektronikoa:	https://www.dovepress.com/pharmacological-mechanism-of-roflumilast-in-the-treatment-of-asthmanda-peer-reviewed-article-DDDT
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!